DENDRITIC CELLS AND DINITROCHLOROBENZENE (DNCB) - A NEW TREATMENT APPROACH TO AIDS

被引：20

作者：

STRICKER, RB

ELSWOOD, BF

ABRAMS, DI

机构：

[1] UNIV CALIF SAN FRANCISCO, SAN FRANCISCO, CA 94143 USA

[2] SAN FRANCISCO GEN HOSP, SAN FRANCISCO, CA 94110 USA

来源：

IMMUNOLOGY LETTERS | 1991年 / 29卷 / 03期

关键词：

AIDS; HIV; DENDRITIC CELL; EPIDERMAL LANGERHANS CELL; DINITROCHLOROBENZENE;

D O I：

10.1016/0165-2478(91)90169-B

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Recent studies suggest that antigen-presenting cells (dendritic cells) may play a key role in the pathogenesis of human immunodeficiency virus (HIV) infection. This observation makes new immunomodulatory treatment stategies desirable. Topical dinitrochlorobenzene (DNCB) is discussed as a possible treatment modality in the context of its proven therapeutic uses and its immunomodulatory effect on dendritic cells. DNCB may be a safe, inexpensive, and widely available treatment option for HIV disease.

引用

页码：191 / 196

页数：6

共 65 条

[1]

ASCHER MS, 1990, J ACQ IMMUN DEF SYND, V2, P95

[2]

BANG D, 1988, Journal of Dermatology (Tokyo), V15, P27

[3]

BELSITO DV, 1984, NEW ENGL J MED, V118, P481

[4]

BRAATHEN LR, 1991, SKIN LANGERHANS DEND, P131